Loading…
The engagement is for evaluating a potential strategic capital raise.
Liminatus Pharma, Inc. announced on July 24, 2025 Liminatus Pharma, Inc. has entered into an engagement agreement with Digital Offering LLC to serve as its exclusive placement agent in connection with the company’s evaluation of a potential strategic capital raise.
Liminatus Pharma, Inc. has a free float of 4,505,200 shares and 26,014,600 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.